Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma.

Br J Cancer · 2010 · PMC2990578 · PMID 20924376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These properties may be significant as the combination of carboplatin and paclitaxel appears to be active in melanoma ( Hauschild et al , 2009a , 2009b ) and is emerging as a standard therapy for metastatic melanoma.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.